Shore Capital Boosts Genus (LON:GNS) Price Target to GBX 2,900

Genus (LON:GNSFree Report) had its price objective upped by Shore Capital from GBX 2,630 to GBX 2,900 in a research note published on Thursday morning, Marketbeat reports. They currently have a buy rating on the stock.

Separately, Deutsche Bank Aktiengesellschaft upped their target price on Genus from GBX 2,250 to GBX 2,550 and gave the stock a “buy” rating in a report on Tuesday, July 15th. Two research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of GBX 2,725.

Get Our Latest Analysis on GNS

Genus Price Performance

Shares of Genus stock opened at GBX 2,690 on Thursday. The stock has a market cap of £1.76 billion, a price-to-earnings ratio of 222.98, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37. The company has a debt-to-equity ratio of 53.12, a quick ratio of 1.08 and a current ratio of 1.80. The stock has a 50 day moving average price of GBX 2,317.70 and a 200-day moving average price of GBX 2,028.46. Genus has a one year low of GBX 1,424 and a one year high of GBX 2,760.

About Genus

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Stories

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.